Scope
NICE PTSD guidance addresses recognition, safety, access and treatment across childhood and adulthood. Trauma-focused psychological interventions are central, with age- and timing-specific choices and narrower roles for medication. The guidance also recognises complex trauma, barriers to trust, depression and substance misuse as factors requiring adapted care rather than automatic exclusion.
Written by House with AI assistance · AI-assisted source check 29 October 2026.
This is House’s summary of the cited guidance. The source check is not an independent clinician review. Open the publication for complete recommendations, exceptions, evidence grades and later amendments.
Assess trauma symptoms, function and immediate risk
- Ask directly about re-experiencing, avoidance, hyperarousal, dissociation, mood or thinking changes and functional impairment. Explore relevant traumatic events even if they occurred long before presentation. [1]
- Assess physical, psychological and social needs as well as risk. If there is significant danger to the person or others, make a safety and risk-management plan during initial treatment planning. [1]
- Agree who monitors care when services share responsibility. During a transfer, do not discharge someone needing ongoing care before a new service has an agreed care plan. [1]
- Avoid treatment environments or triggers that may worsen symptoms or impair engagement. Recognise avoidance, shame and difficulty trusting as potential barriers, and use flexible attendance policies and follow-up after missed appointments. [1]
Distinguish monitoring from debriefing and treatment
- For subthreshold symptoms within a month of trauma, consider active monitoring and arrange follow-up within a month. Do not offer psychologically focused debriefing to prevent or treat PTSD. [1]
- For a child or adolescent below 18 with acute stress disorder or clinically important PTSD symptoms within a month of trauma, consider active monitoring or individual trauma-focused CBT. [1]
- For adults with acute stress disorder or clinically important PTSD symptoms in the month after trauma, offer individual trauma-focused CBT. The listed approaches include cognitive processing, PTSD-focused cognitive therapy, narrative exposure and prolonged exposure. [1]
Choose trauma therapy by age, timing and response
- For children aged 5–6 with PTSD or clinically important symptoms presenting more than a month after trauma, consider individual trauma-focused CBT. [1]
- For ages 7–17 with diagnosed PTSD or clinically important PTSD symptoms, consider individual trauma-focused CBT when presenting 1–3 months after trauma, and offer it when presenting more than 3 months after trauma. [1]
- Use a validated manual and trained supervised practitioners, adapting CBT to developmental age and involving parents as appropriate. Typical treatment is 6–12 sessions, with more when clinically indicated, such as multiple traumas. [1]
- For ages 7–17 with diagnosed PTSD or clinically important PTSD symptoms presenting more than 3 months after trauma, consider EMDR only when the child does not respond to or engage with trauma-focused CBT. Do not offer medication to prevent or treat PTSD below age 18. [1]
Offer evidence-based trauma-focused treatment
- For adults with PTSD or clinically important symptoms presenting more than a month after trauma, offer individual trauma-focused CBT using one of the listed validated approaches. [1]
- Adult trauma-focused CBT should use a validated manual with a trained supervised practitioner, typically over 8–12 sessions and longer when needed. Include trauma processing, arousal management, safety planning and help to overcome avoidance and restore functioning. [1]
- For adult PTSD after non-combat trauma, consider EMDR at 1–3 months if preferred, and offer it after 3 months. This timing recommendation specifically concerns non-combat-related trauma. [1]
- For adults with diagnosed PTSD or clinically important PTSD symptoms presenting more than 3 months after trauma, consider supported computerised trauma-focused CBT if preferred to face-to-face therapy, provided symptoms are not severe, particularly dissociation, and there is no risk of harm to self or others. [1]
- For adults with diagnosed PTSD or clinically important PTSD symptoms presenting more than 3 months after trauma, targeted CBT for problems such as sleep or anger may be considered only when the person cannot or will not engage in trauma-focused treatment, or has residual symptoms afterwards. [1]
Keep medication choices conditional and reviewed
- Do not use medicines, including benzodiazepines, to prevent PTSD in adults. [1]
- If an adult with diagnosed PTSD prefers medication, consider venlafaxine or an SSRI such as sertraline and review treatment regularly. This is a preference-sensitive option, not a replacement of trauma therapy for everyone. [1]
- For adults with diagnosed PTSD, consider an antipsychotic in addition to psychological therapy only for disabling symptoms or behaviours that have not responded to other drug or psychological treatment. A specialist should initiate and regularly review it. [1]
Adapt engagement and sequencing to comorbidity
- Usually treat PTSD before coexisting depression because depression may improve with effective PTSD treatment. Treat depression first if it is severe enough to make PTSD psychological treatment difficult or creates a risk of harm. [1]
- Do not exclude a person from PTSD treatment solely because of alcohol or drug misuse. For complex needs, allow extra time to build trust, address unstable circumstances and barriers to engagement, and plan support after therapy. [1]
- Do not withhold treatment solely because compensation claims or court proceedings are ongoing. Discuss timing and its implications with the person to support an informed decision. [1]
Limitations and use
- This summary does not supply a psychotherapy manual, diagnostic interview or drug-dose and monitoring schedule.
- The child and adult treatment pathways and timing restrictions must remain distinct; adult medication options must not be extrapolated to children.
- Legal and service-organisation details reflect the UK source and require local interpretation.
This summary is selective and does not reproduce every recommendation. Apply the source’s population, setting and eligibility criteria, together with clinical judgement and local policy.
Summary sources
- Post-traumatic stress disorder
Selected recommendation material consulted
Publication details
- Issuing organisation
- NICE
- First published
- 5 December 2018
- Resource type
- Clinical guideline · House clinical summary
- Source setting
- United Kingdom
The source check confirms publication details and the linked edition. It does not certify every recommendation or its suitability for an individual patient. Publisher access conditions may apply.